AARTI DRUGS
Back to Cashflow Statement
|
AARTI DRUGS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-82 Cr | ₹-136 Cr | ₹17 Cr | ₹92 Cr | ₹-81 Cr |
What is the latest Cash Flow from Financing Activities ratio of AARTI DRUGS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-82 Cr |
| Mar2024 | ₹-136 Cr |
| Mar2023 | ₹17 Cr |
| Mar2022 | ₹92 Cr |
| Mar2021 | ₹-81 Cr |
How is Cash Flow from Financing Activities of AARTI DRUGS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-82 Cr | Negative | |
| Mar2024 | ₹-136 Cr | Negative | |
| Mar2023 | ₹17 Cr | -82.02 | |
| Mar2022 | ₹92 Cr | Positive | |
| Mar2021 | ₹-81 Cr | - | |
Compare Cash Flow from Financing Activities of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,398.6 Cr | 0.4% | -5.8% | -15.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,792.0 Cr | 1.4% | 1.2% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,152.0 Cr | -0.5% | -0.6% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,915.0 Cr | 2.1% | 1.5% | 42.2% | Stock Analytics | |
| CIPLA | ₹116,354.0 Cr | 6.4% | 1.6% | -3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,681.0 Cr | 6.2% | 1.6% | 0.2% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | 0.4% |
-5.8% |
-15.3% |
| SENSEX | -0.4% |
0.8% |
-5.3% |
You may also like the below Video Courses